Scarborough Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-342
Closed -$4.62K 686
2026
Q1
$4.62K Buy
342
+2
+0.6% +$28 ﹤0.01% 529
2025
Q4
$4.24K Buy
340
+1
+0.3% +$11 ﹤0.01% 324
2025
Q3
$3.35K Buy
339
+2
+0.6% +$19 ﹤0.01% 332
2025
Q2
$3.01K Buy
+337
New +$2.85K ﹤0.01% 324
2024
Q3
Sell
-346
Closed -$3.67K 442
2024
Q2
$3.67K Buy
346
+17
+5% +$188 ﹤0.01% 281
2024
Q1
$3.93K Sell
329
-11
-3% -$132 ﹤0.01% 272
2023
Q4
$3.68K Buy
+340
New +$3.26K ﹤0.01% 514

Other funds holding VTRS

Scarborough Advisors's VTRS Position: Q2 2026 in Review

Scarborough Advisors sold out of Viatris (VTRS) in Q2 2026, closing a stake of 342 shares — an estimated $4.62K sold.

Scarborough Advisors first reported a position in VTRS in Q4 2023 and held it in 7 quarters. The position peaked at $4.62K in Q1 2026. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Scarborough Advisors reported no remaining Viatris position as of Q2 2026 after selling out during the quarter.
  • Scarborough Advisors sold 342 Viatris shares in Q2 2026, an estimated $4.62K.
  • Scarborough Advisors first reported a position in Viatris in Q4 2023 and held it in 7 quarters.
  • Scarborough Advisors's Viatris position peaked at $4.62K in Q1 2026.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.